Anda belum login :: 19 Apr 2025 05:56 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Nutritional Intervention To Prevent (NIP) Type 1 Diabetes A Pilot Trial
Oleh:
Chase, H. Peter
;
Lescheck, Ellen
;
Rafkin-Mervis, Lisa E.
;
Krause-Steinrauf, Heidi
;
Chritton, Sonia
;
Asare, Smita M.
;
Adams, Sara
;
Skyler, Jay S.
;
Clare-Salzler, Michael
Jenis:
Article from Article
Dalam koleksi:
ICAN: Infant, Child, & Adolescent Nutrition vol. 1 no. 2 (Apr. 2009)
,
page 98-107.
Topik:
diabetes (type 1 and 2)
;
chronic disease management
;
prevent type 1
;
nutritional intervention
Fulltext:
98.pdf
(338.35KB)
Isi artikel
The objective of this study was to describe a pilot trial of using an omega-3 fatty acid (docosahexaenoic acid [DHA]) to prevent islet cell autoimmunity in infants with an increased risk for developing type 1 diabetes (T1D). Infants from pregnant mothers who either have T1D (or the father or a previous child has T1D) and who entered the study in the third trimester or infants younger than age 5 months having a first-degree family member with T1D were eligible for the study. Infants from either group also had to have an increased genetic (HLA) risk for T1D (or multiple first-degree relatives with T1D) to be eligible. The study is a multicenter, 2-arm, randomized, doublemasked clinical trial that will last 4 years (1 year of recruitment and 3 years of treatment). Treatment with DHA (or control) began in the last trimester of pregnancy or in the first 5 months after birth. Inflammatory mediators, including cytokines, chemokines, eicosanoids, and C-reactive protein, are being measured along with fatty acids in maternal and infant blood. Ninety-eight infants were enrolled (41 during pregnancy and 57 in the 5 months after birth). HLA results of the 97 eligible infants (1 infant had a protective 0602 allele and was thus ineligible) showed that 90 have DR3 and/or DR4. Seven infants were enrolled without DR3/4 but who instead had multiple first-degree relatives with T1D. Compliance has been excellent, and no families have discontinued participation. Intervention trials in this high-risk group are feasible but require significant effort to identify potential participants.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)